{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:36:08Z","timestamp":1765294568578},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T00:00:00Z","timestamp":1351814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Subst Abuse Treat Prev Policy"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1747-597x-7-45","type":"journal-article","created":{"date-parts":[[2012,11,2]],"date-time":"2012-11-02T15:14:11Z","timestamp":1351869251000},"source":"Crossref","is-referenced-by-count":6,"title":["Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study"],"prefix":"10.1186","volume":"7","author":[{"given":"Pekka","family":"Rapeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Fabritius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hely","family":"Kalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannu","family":"Alho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,2]]},"reference":[{"key":"224_CR1","doi-asserted-by":"crossref","DOI":"10.18356\/58c4f2e4-en","volume-title":"2007 World Drug Report","author":"United Nations Office on Drugs and Crime","year":"2007","unstructured":"United Nations Office on Drugs and Crime: 2007 World Drug Report. 2007, Vienna:United Nations Office on Drugs and Crime,"},{"key":"224_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","volume":"54","author":"RK Brooner","year":"1997","unstructured":"Brooner RK, King VL, Kidorf M, Schmidt CW, Bigelow GE: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psych. 1997, 54: 71-80. 10.1001\/archpsyc.1997.01830130077015.","journal-title":"Arch Gen Psych"},{"key":"224_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1601-5215.2004.0075.x","volume":"16","author":"MT Abou-Saleh","year":"2004","unstructured":"Abou-Saleh MT, Janca A: The epidemiology of substance misuse and comorbid psychiatric disorders. Acta Neuropsychiatr. 2004, 16: 3-8. 10.1111\/j.1601-5215.2004.0075.x.","journal-title":"Acta Neuropsychiatr"},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/00002508-200207001-00003","volume":"18","author":"EC Strain","year":"2002","unstructured":"Strain EC: Assessment and treatment of comorbid psychiatric disorders in opioid-dependent patients. Clin J Pain. 2002, 18: S14-S27. 10.1097\/00002508-200207001-00003.","journal-title":"Clin J Pain"},{"key":"224_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1747-597X-7-11","volume":"7","author":"HY Lee","year":"2012","unstructured":"Lee HY, Li JH, Wu LT, Wu JS, Yen CF, Tang HP: Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Subst Abuse Treat Prev Policy. 2012, 7: 11-10.1186\/1747-597X-7-11.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"224_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1447-0349.2011.00795.x","volume":"21","author":"D Deering","year":"2012","unstructured":"Deering D, Horn J, Frampton CMA: Clients' perceptions of opioid substitution treatment: An input to improving the quality of treatment. Int J Ment Health Nurs. 2012, 21: 330-339. 10.1111\/j.1447-0349.2011.00795.x.","journal-title":"Int J Ment Health Nurs"},{"key":"224_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.drugalcdep.2007.03.008","volume":"90","author":"JG Bramness","year":"2007","unstructured":"Bramness JG, Kornor H: Benzodiazepine prescription for patients in opioid maintenance treatment in Norway. Drug Alcohol Depend. 2007, 90: 203-209. 10.1016\/j.drugalcdep.2007.03.008.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.drugalcdep.2010.06.013","volume":"112","author":"FJ Eiroa-Orosa","year":"2010","unstructured":"Eiroa-Orosa FJ, Haasen C, Verthein U, Dilg C, Schafer I, Reimer J: Benzodiazepine use among patients in heroin-assisted vs methadone maintenance treatment Findings of the German randomized controlled trial. Drug Alcohol Depend. 2010, 112: 226-233. 10.1016\/j.drugalcdep.2010.06.013.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.drugalcdep.2007.06.016","volume":"92","author":"S Schreiber","year":"2008","unstructured":"Schreiber S, Peles E, Adelson M: Association between improvement in depression, reduced benzodiazepine (BDZ) abuse, and increased psychotropic medication use in methadone maintenance treatment (MMT) patients. Drug Alcohol Depend. 2008, 92: 79-85. 10.1016\/j.drugalcdep.2007.06.016.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1176\/jnp.13.4.527","volume":"13","author":"M Soyka","year":"2001","unstructured":"Soyka M, Horak M, Dittert S, Kagerer S: Less driving impairment on buprenorphine than methadone in drug-dependent patients?. J Neuropsychiatry Clin Neurosci. 2001, 13: 527-528. 10.1176\/appi.neuropsych.13.4.527.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"224_CR11","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1097\/JCP.0b013e31818a6d38","volume":"28","author":"M Soyka","year":"2008","unstructured":"Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, Limmer C, Kuefner H, Hennig-Fast K: Cognitive functioning during methadone and buprenorphine treatment results of a randomized clinical trial. J Clin Psychopharmacol. 2008, 28: 699-703. 10.1097\/JCP.0b013e31818a6d38.","journal-title":"J Clin Psychopharmacol"},{"key":"224_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/1874941000801010005","volume":"1","author":"SM Giacomuzzi","year":"2008","unstructured":"Giacomuzzi SM, Thill C, Riemer Y, Garber K, Ertl M: Buprenorphine-and methadone maintenance treatment: influence on aspects of cognitive and memory performance. Open Addict J. 2008, 1: 5-6. 10.2174\/1874941000801010005.","journal-title":"Open Addict J"},{"key":"224_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drugalcdep.2005.11.008","volume":"83","author":"R Pirastu","year":"2006","unstructured":"Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M: Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend. 2006, 83: 163-168. 10.1016\/j.drugalcdep.2005.11.008.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR14","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3109\/00952990.2011.600381","volume":"37","author":"M Soyka","year":"2011","unstructured":"Soyka M, Limmer C, Lehnert R, Koller G, Martin G, Kuefner H, Kagerer S, Haberthuer A: A Comparison of Cognitive Function in Patients under Maintenance Treatment with Heroin, Methadone, or Buprenorphine and Healthy Controls: An Open Pilot Study. Am J Drug Alcohol Abuse. 2011, 37: 497-508. 10.3109\/00952990.2011.600381.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"224_CR15","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11136-010-9732-3","volume":"20","author":"J De Maeyer","year":"2011","unstructured":"De Maeyer J, Vanderplasschen W, Lammertyn J, van Nieuwenhuizen C, Sabbe B, Broekaert E: Current quality of life and its determinants among opiate-dependent individuals five years after starting methadone treatment. Qual Life Res. 2011, 20: 139-150. 10.1007\/s11136-010-9732-3.","journal-title":"Qual Life Res"},{"key":"224_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1073\/pnas.1206820109","volume":"109","author":"MH Meier","year":"2012","unstructured":"Meier MH, Caspi A, Ambler A, Harrington H, Houts R, Keefe RSE, McDonald K, Ward A, Poulton R, Moffitt TE: Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA. 2012, 109: 1-8.","journal-title":"Proc Natl Acad Sci USA"},{"key":"224_CR17","doi-asserted-by":"publisher","first-page":"b2225","DOI":"10.1136\/bmj.b2225","volume":"338","author":"C McCowan","year":"2009","unstructured":"McCowan C, Kidd B, Fahey T: Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ. 2009, 338: b2225-10.1136\/bmj.b2225.","journal-title":"BMJ"},{"key":"224_CR18","volume-title":"DRUID Driving under the Influence of Drugs, Alcohol and Medicines Project co-funded by the European Commission within the Sixth Framework Programme (2002\u20132006)","author":"K Pil","year":"2008","unstructured":"Pil K, Raes E, Van den Neste T, Goessaert A-S, Veramme J, Verstraete A: Review of existing classification efforts. DRUID Driving under the Influence of Drugs, Alcohol and Medicines Project co-funded by the European Commission within the Sixth Framework Programme (2002\u20132006). 2008, Belgium:Ghent University,"},{"key":"224_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1747-597X-4-6","volume":"4","author":"P Rapeli","year":"2009","unstructured":"Rapeli P, Fabritius C, Kalska H, Alho H: Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals. Subst Abuse Treat Prev Policy. 2009, 4: 6-10.1186\/1747-597X-4-6.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"224_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/01.jcp.0000219050.33008.61","volume":"26","author":"N Lintzeris","year":"2006","unstructured":"Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J: Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J Clin Psychopharmacol. 2006, 26: 274-283. 10.1097\/01.jcp.0000219050.33008.61.","journal-title":"J Clin Psychopharmacol"},{"key":"224_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.drugalcdep.2007.05.019","volume":"91","author":"N Lintzeris","year":"2007","unstructured":"Lintzeris N, Mitchell TB, Bond AJ, Nestor L, Strang J: Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients. Drug Alcohol Depend. 2007, 91: 187-194. 10.1016\/j.drugalcdep.2007.05.019.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1472-6904-11-13","volume":"11","author":"P Rapeli","year":"2011","unstructured":"Rapeli P, Fabritius C, Kalska H, Alho H: Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates. BMC Clin Pharmacol. 2011, 11: 13-10.1186\/1472-6904-11-13.","journal-title":"BMC Clin Pharmacol"},{"key":"224_CR23","first-page":"299","volume-title":"Drug Addiction: Research Frontiers and Treatment Advances","author":"S Spiga","year":"2008","unstructured":"Spiga S, Lintas A, Diana M: Addiction and Cognitive Functions. Drug Addiction: Research Frontiers and Treatment Advances. Edited by: Kuhar MJ. 2008, Oxford: Blackwell Publishing, 299-306. 1139","edition":"1139"},{"key":"224_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","volume":"18","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF: Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004, 18: 37-48. 10.2165\/00023210-200418010-00004.","journal-title":"CNS Drugs"},{"key":"224_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10072-009-0033-y","volume":"30","author":"I Cancelli","year":"2009","unstructured":"Cancelli I, Beltrame M, Gigli GL, Valente M: Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci. 2009, 30: 87-92. 10.1007\/s10072-009-0033-y.","journal-title":"Neurol Sci"},{"key":"224_CR26","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1532-5415.2008.01737.x","volume":"56","author":"ML Chew","year":"2008","unstructured":"Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, Mahmoud RA, Kirshner MA, Sorisio DA, Bies RR, Gharabawi G: Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc. 2008, 56: 1333-1341. 10.1111\/j.1532-5415.2008.01737.x.","journal-title":"J Am Geriatr Soc"},{"key":"224_CR27","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0733-8619(05)70371-6","volume":"16","author":"KJ Meador","year":"1998","unstructured":"Meador KJ: Cognitive side effects of medications. Neurol Clin. 1998, 16: 141-155. 10.1016\/S0733-8619(05)70371-6.","journal-title":"Neurol Clin"},{"key":"224_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/gps.1093","volume":"19","author":"JM Starr","year":"2004","unstructured":"Starr JM, McGurn B, Whiteman M, Pattie A, Whalley LJ, Deary IJ: Life long changes in cognitive ability are associated with prescribed medications in old age. Int J Geriatr Psychiatry. 2004, 19: 327-332. 10.1002\/gps.1093.","journal-title":"Int J Geriatr Psychiatry"},{"key":"224_CR29","volume-title":"Structured Clinical Interview for DSM-IV, Axis I Disorders (SCID-I)","author":"MB First","year":"1997","unstructured":"First MB, Gibbon M, Spitzer R, Williams JB, Benjamin L: Structured Clinical Interview for DSM-IV, Axis I Disorders (SCID-I). 1997, New York: American PsychiatricPress,"},{"key":"224_CR30","volume-title":"Wechsler Adult Intelligence Scale - Revised (WAIS-R). Finnish version","author":"D Wechsler","year":"1993","unstructured":"Wechsler D: Wechsler Adult Intelligence Scale - Revised (WAIS-R). Finnish version. 1993, Helsinki: Psykologien Kustannus"},{"key":"224_CR31","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/S0376-8716(03)00058-9","volume":"70","author":"CN Chiang","year":"2003","unstructured":"Chiang CN, Hawks RL: Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend. 2003, 70: S39-S47. 10.1016\/S0376-8716(03)00058-9.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR32","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2165\/00003495-200969050-00006","volume":"69","author":"JS Orman","year":"2009","unstructured":"Orman JS, Keating GM: Buprenorphine\/Naloxone a review of its use in the treatment of opioid dependence. Drugs. 2009, 69: 577-607. 10.2165\/00003495-200969050-00006.","journal-title":"Drugs"},{"key":"224_CR33","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2165\/00003088-200443050-00005","volume":"43","author":"DS Harris","year":"2004","unstructured":"Harris DS, Mendelson JE, Lin ET, Upton RA, Jones RT: Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionality. Clin Pharmacokinet. 2004, 43: 329-340. 10.2165\/00003088-200443050-00005.","journal-title":"Clin Pharmacokinet"},{"key":"224_CR34","first-page":"69","volume":"6","author":"J Nelson","year":"1999","unstructured":"Nelson J, Chouinard G: Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Can J Clin Pharmacol. 1999, 6: 69-83.","journal-title":"Can J Clin Pharmacol"},{"key":"224_CR35","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jpsychires.2005.07.011","volume":"40","author":"A Nocon","year":"2006","unstructured":"Nocon A, Wittchen HU, Pfister H, Zimmermann P, Lieb R: Dependence symptoms in young cannabis users? A prospective epidemiological study. J Psychiatr Res. 2006, 40: 394-403. 10.1016\/j.jpsychires.2005.07.011.","journal-title":"J Psychiatr Res"},{"key":"224_CR36","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1093\/alcalc\/34.4.636","volume":"34","author":"AP Shakeshaft","year":"1999","unstructured":"Shakeshaft AP, Bowman JA, Sanson-Fisher RW: A comparison of two retrospective measures of weekly alcohol consumption: diary and quantity\/frequency index. Alcohol Alcohol. 1999, 34: 636-645.","journal-title":"Alcohol Alcohol"},{"key":"224_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/0269881105056644","volume":"20","author":"EJK Wadsworth","year":"2006","unstructured":"Wadsworth EJK, Moss SC, Simpson SA, Smith AP: Cannabis use, cognitive performance and mood in a sample of workers. J Psychopharmacol. 2006, 20: 14-23.","journal-title":"J Psychopharmacol"},{"key":"224_CR38","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11065-010-9146-6","volume":"20","author":"S Bava","year":"2010","unstructured":"Bava S, Tapert SF: Adolescent Brain Development and the Risk for Alcohol and Other Drug Problems. Neuropsychol Rev. 2010, 20: 398-413. 10.1007\/s11065-010-9146-6.","journal-title":"Neuropsychol Rev"},{"key":"224_CR39","unstructured":"Effect Size Calculator. http:\/\/www.cemcentre.org\/renderpage.asp?linkID=30325017 ,"},{"key":"224_CR40","volume-title":"Test for Attentional Performance (TAP)","author":"P Zimmermann","year":"1995","unstructured":"Zimmermann P, Fimm B: Test for Attentional Performance (TAP). 1995, Herzogenrath: PsyTest"},{"key":"224_CR41","volume-title":"Wechler Memory Scale - Third Edtion","author":"D Wechsler","year":"1997","unstructured":"Wechsler D: Wechler Memory Scale - Third Edtion. 1997, San Antonio, TX: ThePsychological Corporation,"},{"key":"224_CR42","volume-title":"The Revised Visual Retention Test","author":"A Benton","year":"1963","unstructured":"Benton A: The Revised Visual Retention Test. 1963, New York: PsychologicalCorporation,"},{"key":"224_CR43","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0304-3959(02)00461-X","volume":"103","author":"PW Walker","year":"2003","unstructured":"Walker PW, Klein D, Kasza L: High dose methadone and ventricular arrhythmias: a report of three cases. Pain. 2003, 103: 321-324. 10.1016\/S0304-3959(02)00461-X.","journal-title":"Pain"},{"key":"224_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1089\/152702900320685","volume":"1","author":"AB Gerard","year":"2000","unstructured":"Gerard AB, McElroy MK, Taylor MJ, Grant I, Powell FL, Holverda S, Sentse N, West JB: Six percent oxygen enrichment of room air at simulated 5000 m altitude improves neuropsychological function. High Alt Med Biol. 2000, 1: 51-61. 10.1089\/152702900320685.","journal-title":"High Alt Med Biol"},{"key":"224_CR45","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.clinthera.2007.08.007","volume":"29","author":"M Escher","year":"2007","unstructured":"Escher M, Daali Y, Chabert J, Hopfgartner G, Dayer P, Desmeules J: Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: A randomized, double-blind, placebo-controlled, crossover study. Clin Ther. 2007, 29: 1620-1631. 10.1016\/j.clinthera.2007.08.007.","journal-title":"Clin Ther"},{"key":"224_CR46","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/00004714-200102000-00014","volume":"21","author":"KR Dyer","year":"2001","unstructured":"Dyer KR, White JM, Foster DJR, Bochner H, Menelaou A, Somogyi AA: The relationship between mood state and plasma methadone concentration in maintenance patients. J Clin Psychopharmacol. 2001, 21: 78-84. 10.1097\/00004714-200102000-00014.","journal-title":"J Clin Psychopharmacol"},{"key":"224_CR47","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.2165\/00003088-200241140-00003","volume":"41","author":"CB Eap","year":"2002","unstructured":"Eap CB, Buclin T, Baumann P: Interindividual variability of the clinical pharmacokinetics of methadone - Implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002, 41: 1153-1193. 10.2165\/00003088-200241140-00003.","journal-title":"Clin Pharmacokinet"},{"key":"224_CR48","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1176\/jnp.2007.19.2.164","volume":"19","author":"M Ragnehed","year":"2007","unstructured":"Ragnehed M, Hakansson I, Nilsson M, Lundberg P, Soderfeldt B, Engstrom M: Influence of diazepam on clinically designed FMRI. J Neuropsychiatry Clin Neurosci. 2007, 19: 164-172. 10.1176\/appi.neuropsych.19.2.164.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"224_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4088\/JCP.v66n0709","volume":"66","author":"SA Stewart","year":"2005","unstructured":"Stewart SA: The effects of benzodiazepines on cognition. J Clin Psychiatry. 2005, 66: 9-13.","journal-title":"J Clin Psychiatry"},{"key":"224_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2165\/11586580-000000000-00000","volume":"28","author":"MP Fortin","year":"2011","unstructured":"Fortin MP, Rouch I, Dauphinot V, Gedeon C, Genthon S, Bonnefoy M, Krolak-Salmon P: Effects of Anticholinergic Drugs on Verbal Episodic Memory Function in the Elderly A Retrospective, Cross-Sectional Study. Drugs Aging. 2011, 28: 195-204. 10.2165\/11586580-000000000-00000.","journal-title":"Drugs Aging"},{"key":"224_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0306-4603(99)00011-8","volume":"24","author":"MD Horner","year":"1999","unstructured":"Horner MD, Waid LR, Johnson DE, Latham PK, Anton RF: The relationship of cognitive functioning to amount of recent and lifetime alcohol consumption in outpatient alcoholics. Addict Behav. 1999, 24: 449-453. 10.1016\/S0306-4603(99)00011-8.","journal-title":"Addict Behav"},{"key":"224_CR52","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archpsyc.58.10.909","volume":"58","author":"HG Pope Jr","year":"2001","unstructured":"Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D: Neuropsychological performance in long-term cannabis users. Arch Gen Psych. 2001, 58: 909-915. 10.1001\/archpsyc.58.10.909.","journal-title":"Arch Gen Psych"},{"key":"224_CR53","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/j.1360-0443.2011.03745.x","volume":"107","author":"JG Bramness","year":"2012","unstructured":"Bramness JG, Skurtveit S, Morland J, Engeland A: An increased risk of motor vehicle accidents after prescription of methadone. Addiction. 2012, 107: 967-972. 10.1111\/j.1360-0443.2011.03745.x.","journal-title":"Addiction"},{"key":"224_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.drugalcdep.2011.10.022","volume":"123","author":"P Corsenac","year":"2012","unstructured":"Corsenac P, Lagarde E, Gadegbeku B, Delorme B, Tricotel A, Castot A, Moore N, Philip P, Laumon B, Orriols L: Road traffic crashes and prescribed methadone and buprenorphine: A french registry-based case\u2013control study. Drug Alcohol Depend. 2012, 123: 91-97. 10.1016\/j.drugalcdep.2011.10.022.","journal-title":"Drug Alcohol Depend"},{"key":"224_CR55","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/nrn1201","volume":"4","author":"A Baddeley","year":"2003","unstructured":"Baddeley A: Working memory: Looking back and looking forward. Nat Rev Neurosci. 2003, 4: 829-839.","journal-title":"Nat Rev Neurosci"},{"key":"224_CR56","first-page":"436","volume":"19","author":"A W\u00fcrz","year":"2009","unstructured":"W\u00fcrz A, Sungur MZ: Combining Cognitive Behavioural Therapy and Pharmacotherapy in the Treatment of Anxiety Disorders: True Gains or False Hopes?. Bulletin of Clinical Psychopharmacology. 2009, 19: 436-446.","journal-title":"Bulletin of Clinical Psychopharmacology"},{"key":"224_CR57","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0022-5371(83)90229-3","volume":"22","author":"A Sunderland","year":"1983","unstructured":"Sunderland A: Do laboratory tests predict everyday memory? A neuropsychological study. J Verb Learn Verb Behav. 1983, 22: 341-357. 10.1016\/S0022-5371(83)90229-3.","journal-title":"J Verb Learn Verb Behav"},{"key":"224_CR58","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1521-0391.2009.00005.x","volume":"19","author":"EF McCance-Katz","year":"2010","unstructured":"McCance-Katz EF, Sullivan LE, Nallani S: Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review. Am J Addict. 2010, 19: 4-16. 10.1111\/j.1521-0391.2009.00005.x.","journal-title":"Am J Addict"},{"key":"224_CR59","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/arclin\/13.3.259","volume":"13","author":"RA Stein","year":"1998","unstructured":"Stein RA, Strickland TL: A review of the neuropsychological effects of commonly used prescription medications. Arch Clin Neuropsychol. 1998, 13: 259-284.","journal-title":"Arch Clin Neuropsychol"},{"key":"224_CR60","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1037\/a0016956","volume":"14","author":"J DeCoster","year":"2009","unstructured":"DeCoster J, Iselin AM, Gallucci M: A conceptual and empirical examination of justifications for dichotomization. Psychol Methods. 2009, 14: 349-366.","journal-title":"Psychol Methods"},{"key":"224_CR61","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.pnpbp.2011.11.008","volume":"36","author":"R Kitajima","year":"2012","unstructured":"Kitajima R, Miyamoto S, Tenjin T, Ojima K, Ogino S, Miyake N, Fujiwara K, Funamoto Y, Arai J, Tsukahara S: Effects of tapering of long-term benzodiazepines on cognitive function in patients with schizophrenia receiving a second-generation antipsychotic. Prog Neuropsychopharmacol Biol Psychiatry. 2012, 36: 300-306. 10.1016\/j.pnpbp.2011.11.008.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"224_CR62","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1017\/S003329179800734X","volume":"29","author":"C Kilic","year":"1999","unstructured":"Kilic C, Curran HV, Noshirvani H, Marks IM, Basoglu M: Long-term effects of alprazolam on memory: a 3\u20135 year follow-up of agoraphobia\/panic patients. Psychol Med. 1999, 29: 225-231. 10.1017\/S003329179800734X.","journal-title":"Psychol Med"},{"key":"224_CR63","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1017\/S0033291703008213","volume":"33","author":"HV Curran","year":"2003","unstructured":"Curran HV, Collins R, Fletcher S, Kee SCY, Woods B, Iliffe S: Older adults and withdrawal from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003, 33: 1223-1237. 10.1017\/S0033291703008213.","journal-title":"Psychol Med"},{"key":"224_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0887-6177(03)00096-9","volume":"19","author":"MJ Barker","year":"2004","unstructured":"Barker MJ, Greenwood KM, Jackson M, Crowe SF: Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. Arch Clin Neuropsychol. 2004, 19: 437-454. 10.1016\/S0887-6177(03)00096-9.","journal-title":"Arch Clin Neuropsychol"},{"key":"224_CR65","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/archinte.167.8.781","volume":"167","author":"JT Hanlon","year":"2007","unstructured":"Hanlon JT, Rubin SM, Shorr RI: A drug burden index to define the functional burden of medications in older people. Arch Intern Med. 2007, 167: 781-787. 10.1001\/archinte.167.8.781.","journal-title":"Arch Intern Med"},{"key":"224_CR66","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/00004714-199904000-00003","volume":"19","author":"K Rickels","year":"1999","unstructured":"Rickels K, Lucki I, Schweizer E, Garcia-Espana F, Case WG: Psychomotor performance of long-term benzodiazepine users before, during, and after benzodiazepine discontinuation. J Clin Psychopharmacol. 1999, 19: 107-113. 10.1097\/00004714-199904000-00003.","journal-title":"J Clin Psychopharmacol"},{"key":"224_CR67","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1037\/1064-1297.14.2.157","volume":"14","author":"SA Gruber","year":"2006","unstructured":"Gruber SA, Silveri MM, Renshaw PF, Tzilos GK, Pollack M, Kaufman MJ, Yurgelun-Todd DA: Methadone maintenance improves cognitive performance after two months of treatment. Exp Clinic Psychopharmacol. 2006, 14: 157-164.","journal-title":"Exp Clinic Psychopharmacol"},{"key":"224_CR68","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/1471-2202-11-118","volume":"11","author":"C Bartels","year":"2010","unstructured":"Bartels C, Wegrzyn M, Wiedl A, Ackermann V, Ehrenreich H: Practice effects in healthy adults: a longitudinal study on frequent repetitive cognitive testing. BMC Neurosci. 2010, 11: 118-10.1186\/1471-2202-11-118.","journal-title":"BMC Neurosci"},{"key":"224_CR69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1076\/clin.16.1.57.8329","volume":"16","author":"MR Basso","year":"2002","unstructured":"Basso MR, Carona FD, Lowery N, Axelrod BN: Practice effects on the WAIS-III across 3- and 6-month Intervals. Clin Neuropsychol. 2002, 16: 57-63. 10.1076\/clin.16.1.57.8329.","journal-title":"Clin Neuropsychol"},{"key":"224_CR70","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1747-597X-3-23","volume":"3","author":"J Prosser","year":"2008","unstructured":"Prosser J, Eisenberg D, Davey E, Steinfeld M, Cohen L, London E, Galynker I: Character pathology and neuropsychological test performance in remitted opiate dependence. Subst Abuse Treat Prev Policy. 2008, 3: 23-10.1186\/1747-597X-3-23.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"224_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.drugalcdep.2011.07.001","volume":"120","author":"S Loeber","year":"2012","unstructured":"Loeber S, Nakovics H, Kniest A, Kiefer F, Mann K, Croissant B: Factors affecting cognitive function of opiate-dependent patients. Drug Alcohol Depend. 2012, 120: 81-87. 10.1016\/j.drugalcdep.2011.07.001.","journal-title":"Drug Alcohol Depend"}],"container-title":["Substance Abuse Treatment, Prevention, and Policy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1747-597X-7-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1747-597X-7-45\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1747-597X-7-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T12:44:54Z","timestamp":1594817094000},"score":1,"resource":{"primary":{"URL":"https:\/\/substanceabusepolicy.biomedcentral.com\/articles\/10.1186\/1747-597X-7-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,2]]},"references-count":71,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1186\/1747-597x-7-45","relation":{},"ISSN":["1747-597X"],"issn-type":[{"value":"1747-597X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,2]]},"article-number":"45"}}